MKI67 and cancer: Specifically, the subgroup with nonunanimous outcomes of women under 50 years of age that have luminal cancer, NST histological type, grade III tumor, and Ki67 above 15% is accurately predicted by our model in both cohorts, with increased accuracy from AUC 0.89 to AUC 0.94 when imaging is utilized.